CLNN (Clene Inc. Common Stock) Stock Analysis - SEC Filings

Clene Inc. Common Stock (CLNN) is a publicly traded Healthcare sector company. As of May 21, 2026, CLNN trades at $6.72 with a market cap of $86.76M and a P/E ratio of -1.19. CLNN moved +7.60% today. Year to date, CLNN is +19.79%; over the trailing twelve months it is +165.38%. Its 52-week range spans $2.28 to $13.50. Analyst consensus is strong buy with an average price target of $32.20. Rallies surfaces CLNN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find CLNN SEC filings?

Rallies organizes CLNN SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

CLNN Key Metrics

Key financial metrics for CLNN
MetricValue
Price$6.72
Market Cap$86.76M
P/E Ratio-1.19
EPS$-5.67
Dividend Yield0.00%
52-Week High$13.50
52-Week Low$2.28
Volume201
Avg Volume0
Revenue (TTM)$342.00K
Net Income$-39.40M
Gross Margin79.53%

Latest CLNN News

Recent CLNN Insider Trades

  • Ugwumba Chidozie sold 73.30K (~$454.44K) on May 12, 2026.
  • Ugwumba Chidozie sold 22.18K (~$149.69K) on May 11, 2026.
  • Ugwumba Chidozie sold 72.88K (~$495.61K) on May 4, 2026.

CLNN Analyst Consensus

5 analysts cover CLNN: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $32.20.

Common questions about CLNN

Where can I find CLNN SEC filings?
Rallies organizes CLNN SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show CLNN 10-K and 10-Q filings?
Rallies organizes CLNN SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is CLNN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CLNN. It does not provide personalized investment advice.
CLNN

CLNN